Clinical validation and production upscaling of a novel product for healing of Pressure Ulcers, Leg Ulcers and Diabetic Foot Ulcers.

Project Information

DERMAREP

Grant agreement ID: 869943

DOI 10.3030/869943

Project closed

EC signature date 30 September 2019

Start date 1 October 2019

End date 31 March 2023

Funded under

• Horizon 2020 Framework Programme

Total cost € 4 284 339,29

EU contribution € 2 999 037,50

Coordinated by

BIOVOTEC AS
Norway

Deliverables

Websites, patent fillings, videos etc. (1)

Project Web site

Documents, reports (2)

Data Management Plan (DMP)

Plan for dissemination and communication activities during the project (updated yearly)